ArriVent BioPharma Current Assets

ArriVent BioPharma (AVBP) currently reports a current assets of $390M as of June 2026. That compares with $250M in the prior-year period — up 57.6% year over year. Use the charts on this page to explore ArriVent BioPharma's current assets history and peer comparisons.

ArriVent BioPharma's current assets increased from $250M to $390M — a 57.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ArriVent BioPharma reported $390M in current assets as of June 2026. That compares with $250M in the prior-year period — up 57.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ArriVent BioPharma, and consider following AVBP for alerts when major investors trade the stock.